Los resultados del estudio de referencia RESONATE-2 confirman el beneficio en supervivencia sostenida de IMBRUVICA® (ibrutinib) para el tratamiento de primera línea de la leucemia linfocítica crónica con un seguimiento de hasta 10 años
June 17, 2024 11:05 ET
|
Janssen Cilag International NV
Los datos de RESONATE-2 presentados en el Congreso de la Asociación Europea de Hematología (EHA) de 2024 proporcionan los resultados y datos de seguridad a más largo plazo jamás comunicados para un...
Global Small-Scale LNG Market Report 2024-2032: Rising Utilization in Transportation and Power Generation Fostering Market Growth
June 17, 2024 11:03 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Global Small-Scale LNG Market Report by Terminal Type, Mode of Supply, Storage Tank Type, Application, and Region 2024-2032" report has been added to ...
SPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sprout Social, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
June 17, 2024 11:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
June 17, 2024 11:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
Global Automotive Climate Control Systems Market Size To Worth USD 18.93 Billion By 2033 | CAGR Of 6.20%
June 17, 2024 11:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 17, 2024 (GLOBE NEWSWIRE) -- The Global Automotive Climate Control Systems Market Size is to Grow from USD 10.37 Billion in 2023 to USD 18.93 Billion by 2033, at a...
Low-Profile Additive Market to Surpass $ 1.90 Billion by 2033, Driven by 8.5% Annual Growth
June 17, 2024 11:00 ET
|
The Brainy Insights
Newark, June 17, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 0.84 Billion Low-Profile Additive market will reach USD 1.90 Billion by 2033. Rapidly growing demand for Advanced...
Personalized Nutrition Global Strategic Business Report 2024
June 17, 2024 10:57 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Personalized Nutrition - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lamb Weston Holdings, Inc. (LW)
June 17, 2024 10:48 ET
|
Gainey McKenna & Egleston
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of...
Biologics Global Strategic Business Report 2024: Market to Reach $656.8 Billion by 2030 with Recombinant Therapeutic Proteins Accounting for $246.6 Billion
June 17, 2024 10:47 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Biologics is estimated...
Les résultats issus de l’étude RESONATE-2 de référence confirment le bénéfice durable en matière de survie d’IMBRUVICA® (ibrutinib) dans le traitement de première intention de la leucémie lymphoïde chronique avec une durée de suivi allant jusqu’à 10 ans
June 17, 2024 10:41 ET
|
Janssen Cilag International NV
Les données issues de RESONATE-2 présentées au congrès 2024 de l’European Hematology Association (EHA) fournissent des résultats et des données de sécurité à plus long terme que ceux jamais rapportés...